NSE
Aurobindo Pharma LimitedAUROPHARMA
Aurobindo Pharma is a major generics and API company.
| Key products | US & Europe generics, APIs, injectables, biosimilars. |
|---|---|
| Geography | US, Europe, India. |
| Competitors | Sun Pharma, Cipla, Dr Reddy's. |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Buy Back
ex 2026-04-17
Competitive landscape — the read
vs mapped peers| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | CIPLA | +₹1,527.1 Cr | 39 | — | +1 | +11 | 34 |
| 2 | MANKIND | +₹445.9 Cr | 38 | — | — | — | — |
| 3 | ALKEM | +₹103.5 Cr | 33 | — | — | -2 | 6 |
| 4 | AUROPHARMAThis | +₹0 Cr | 2 | — | — | — | — |
| 5 | DRREDDY | +₹0 Cr | 4 | — | — | +15 | 32 |
| 6 | SUNPHARMA | +₹0 Cr | 6 | — | +2 | +9 | 29 |
| 7 | TORNTPHARM | +₹0 Cr | 2 | — | — | — | — |
| 8 | LUPIN | +₹0 Cr | 4 | — | — | — | — |
| 9 | ZYDUSLIFE | +₹0 Cr | 1 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — AUROPHARMA day by day
- 2026-06-12FilingAurobindo Pharma Limited has informed the Exchange about General UpdatesGeneral
- 2026-06-11FilingAurobindo Pharma Limited has informed the Exchange about Copy of Newspaper PublicationCompliance
- 2026-06-09FilingAurobindo Pharma Limited has informed the Exchange about Schedule of meetInvestor Call
- 2026-04-17ActionBuy BackBuyback
- 2025-10-16BlockSELL · ₹11.8 CrGOLDMAN SACHS (SINGAPORE) PTE.- ODI
- 2025-10-16BlockBUY · ₹11.8 CrGOLDMAN SACHS BANK EUROPESE - ODI
- 2025-08-08ActionInterim Dividend - Rs 4 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2
- 1
- 2
2 deals · 2025-10-16 → 2025-10-16
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2025-10-16 | GOLDMAN SACHS (SINGAPORE) PTE.- ODI | HNI / other | SELL | ₹11.8 Cr |
| 2025-10-16 | GOLDMAN SACHS BANK EUROPESE - ODI | HNI / other | BUY | ₹11.8 Cr |
2 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on AUROPHARMA
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.